Here you will find posts related to the most groundbreaking science that is available to us as it pertains to gluten intolerance and brain health. We all have the gift of brain plasticity, meaning that if we apply the conclusions of these studies to our daily lives we can actually grow new brain cells!
The science surrounding the ketogenic diet expands day by day. In today’s video I will explore some of the science that shows a relationship between the ketogenic diet and increased brain glutathione levels, and explain why that matters for brain health. The full study can be found here. Continue reading
Over the past 10 years, in the various books that I have written, there has been a persistent emphasis on the importance of DHA, an omega-3, in terms of brain health. DHA represents over 90% of all the omega-3, polyunsaturated fatty acids in the brain, and further, it’s 10 to 20% of all the brain’s fat. DHA is especially concentrated in the gray matter, and is also an important part of the cellular membrane of neurons. DHA also has an important role to play in the functioning and structure of mitochondria, the release of neurotransmitters, the expression of DNA, the creation of the myelin insulation around every neuron, the management of neuroinflammation, and even the growth and differentiation of brain cells.
DHA plays a particularly important role in the frontal lobes, allowing us to maintain executive function, pay attention to the various tasks in which we are engaged, and even plan for the future and solving problems. Continue reading
Right now, I am in the middle of reading the New York Times bestseller Why We Sleep by Matthew Walker, PhD. This is an incredibly informative book with absolutely brilliant supportive science that really explains what is going on when we are sleeping.
Over the past several years I’ve emphasized the critically important role that sleep plays, not only in terms of cognitive health and functionality, but with respect to general health as well. Quoting from Dr. Walker’s book: Continue reading
Osteoporosis and low bone mass (osteopenia) represent a major public health threat here in the United States, affecting over 53 million American women and men aged 50 and older. To be clear, this represents more than half of the people in this age group.
Certainly, the main issue that people become concerned with when discussing osteoporosis is the dramatically increased risk of associated bone fracture, of which fractures of the vertebrae are the most common. Of course, associated hip fractures remain extremely important as well. In fact, as published in the Journal of the American Medical Association, nearly 65,000 women die from complications of hip fracture each year, and the risk of death within the first 6 to 12 months after hip fracture is an astounding 25%. Continue reading
It is certainly clear that our most pervasive chronic conditions share a common feature in terms of their underlying cause. Whether we are talking about coronary artery disease, hypertension, diabetes, depression, rheumatoid arthritis, or even Alzheimer’s disease, what current medical literature reveals is the powerful role that inflammation plays in these and other common conditions.
Ultimately, the main issue with higher levels of inflammation that manifests as damage to tissue is the fact that when inflammation has been turned on, it increases the production of damaging free radicals, a situation we call oxidative stress. When oxidative stress is running rampant, damage occurs to our proteins, and fat, and even our DNA. Continue reading
This past summer, Leize and I spent a lot of time in British Columbia. In fact, if you are following my live videos on Facebook, you might recall several entries that called attention to the massive fires that were raging through both the B.C mainland and Vancouver Island. While fires in the Northwest are not uncommon, this year’s events were unprecedented in terms of their scope and duration.
As I pondered the reasons for what we were observing, I naturally defaulted to the idea that, front and center, this was yet another manifestation of climate change. But just this morning I learned that there is another sinister player that appears to be be playing a major role in increasing the frequency and intensity of these wildfires.
By: Austin Perlmutter, M.D.
Electronic cigarettes (commonly known as e-cigarettes) are a relatively new phenomenon. They’ve been discussed by some as a safer alternative to regular cigarettes, and have seen massive spikes in popularity over the last several years. Like many new technologies, it’s taken a bit of time for research to catch up with marketing. Unfortunately, this window has allowed for an incredible surge in e-cigarette use within one of our most vulnerable populations.
In November of 2018, the CDC released a report on e-cigarette use in American youth. The results show an epidemic, with 1 in 5 high school students and 1 in 20 middle school students using these products this year. These shocking statistics show that e-cigarette users increased from 1.5% of high school students in 2011 to 20.8% in 2018. Even more shocking, the total number of high schoolers using e-cigarettes increased by 78% from 2017 to 2018. Continue reading
It’s becoming quite common these days to see news releases documenting the failure of yet another experimental drug for the treatment of Alzheimer’s disease. In fact, one major pharmaceutical company, Pfizer, indicated in February of this year that they were no longer going to pursue efforts to develop a drug to treat this disease, which is now reaching epidemic proportions.
That said, millions of Americans are already taking medication that is FDA approved, to “treat” their Alzheimer’s disease. Since these medications are FDA approved, one would expect that they’ve been extensively tested and proven not only safe, but effective as well. Continue reading
I’ve often been quoted as stating that there is no pharmaceutical approach that has meaningful effectiveness on the treatment of Alzheimer’s disease. Unfortunately, I have to continue to make this claim. As was recently reported in the journal Neurology:
Despite great scientific efforts to find treatments for Alzheimer’s disease (AD), only 5 medications are marketed, with limited beneficial effects on symptoms, on a limited proportion of patients, without modification of disease course. The prevalence of AD doubles every 5 years reaching an alarming rate of 50% in those aged 85 years and older. In the context of the demographic trends of modern society, where the elderly are the fastest growing segment of the population, identification of new therapeutic targets that may prevent, delay, or cure AD is critically needed. (italics added).
The authors reemphasize what we know: that there is no silver bullet available now, or in the foreseeable future, that will help with this devastating and fatal condition. Continue reading
Asthma is the world’s most common respiratory disorder, and, studies have found, is often associated with increased rates of mortality and decreased quality of life. Thus, it’s obvious that keeping asthma at bay is in our collective best interests. Continue reading